FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group Paliperidone Extended-Release Tablets Recall

PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister pa…

The Harvard Drug Group · Livonia, MI

Risk level
Class II
Reported by FDA
Mar 16, 2022
Recall ID
D-0649-2022
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Paliperidone Extended-Release Tablets starting Feb 28, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0649-2022 on Mar 16, 2022. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, India. Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC: 0904-6937-61

Lot numbers, UPCs & expiration codes

Lot #: N00522, Exp. Date 09/2022; N00618, Exp. Date 11/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0649-2022
Classification
Class II
Status
Terminated
Recall initiated
Feb 28, 2022
FDA report date
Mar 16, 2022
Quantity
174 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-0649-2022, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
89681
Address
17187 N Laurel Park Dr Ste 300
Code information
Lot #: N00522, Exp. Date 09/2022; N00618, Exp. Date 11/2022
Postal code
48152-2600
Report date
Mar 16, 2022
Product type
Drugs
Recall number
D-0649-2022
Classification
Class II
Recalling firm
The Harvard Drug Group
Product quantity
174 cartons
Termination date
Jun 8, 2023
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, India. Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC: 0904-6937-61
Distribution pattern
Nationwide within the United States
Recall initiation date
Feb 28, 2022
Initial firm notification
Letter
Center classification date
Mar 9, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0649-2022, published Mar 16, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls